Donna K Finch1, Valerie R Stolberg2, John Ferguson1, Henrih Alikaj2, Mohamed R Kady2, Bradley W Richmond3, Vasiliy V Polosukhin3, Timothy S Blackwell3,4,5,6, Lisa McCloskey7, Jeffrey L Curtis7,8,9, Christine M Freeman2,7,8. 1. 1 Respiratory, Inflammation and Autoimmunity, MedImmune Ltd., Cambridge, United Kingdom. 2. 2 Research Service, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan. 3. 3 Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine. 4. 4 Department of Cell and Developmental Biology and. 5. 5 Department of Cancer Biology, Vanderbilt University School of Medicine, Nashville, Tennessee. 6. 6 Veterans Affairs Tennessee Valley Healthcare System, Nashville, Tennessee. 7. 7 Pulmonary and Critical Care Medicine Division, Department of Internal Medicine, University of Michigan Health System, Ann Arbor, Michigan. 8. 8 Graduate Program in Immunology, University of Michigan, Ann Arbor, Michigan; and. 9. 9 Pulmonary and Critical Care Medicine Section, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan.
Abstract
RATIONALE: Lung natural killer cells (NKs) kill a greater percentage of autologous lung parenchymal cells in chronic obstructive pulmonary disease (COPD) than in nonobstructed smokers. To become cytotoxic, NKs require priming, typically by dendritic cells (DCs), but whether priming occurs in the lungs in COPD is unknown. METHODS: We used lung tissue and in some cases peripheral blood from patients undergoing clinically indicated resections to determine in vitro killing of CD326+ lung epithelial cells by isolated lung CD56+ NKs. We also measured the cytotoxicity of unprimed blood NKs after preincubation with lung DCs. To investigate mechanisms of DC-mediated priming, we used murine models of COPD induced by cigarette smoke (CS) exposure or by polymeric immunoglobulin receptor (pIgR) deficiency, and blocked IL-15Rα (IL-15 receptor α subunit) trans-presentation by genetic and antibody approaches. RESULTS: Human lung NKs killed isolated autologous lung epithelial cells; cytotoxicity was increased (P = 0.0001) in COPD, relative to smokers without obstruction. Similarly, increased lung NK cytotoxicity compared with control subjects was observed in CS-exposed mice and pIgR-/- mice. Blood NKs both from smokers without obstruction and subjects with COPD showed minimal epithelial cell killing, but in COPD, preincubation with lung DCs increased cytotoxicity. NKs were primed by CS-exposed murine DCs in vitro and in vivo. Inhibiting IL-15Rα trans-presentation eliminated NK priming both by murine CS-exposed DCs and by lung DCs from subjects with COPD. CONCLUSIONS: Heightened NK cytotoxicity against lung epithelial cells in COPD results primarily from lung DC-mediated priming via IL-15 trans-presentation on IL-15Rα. Future studies are required to test whether increased NK cytotoxicity contributes to COPD pathogenesis.
RATIONALE: Lung natural killer cells (NKs) kill a greater percentage of autologous lung parenchymal cells in chronic obstructive pulmonary disease (COPD) than in nonobstructed smokers. To become cytotoxic, NKs require priming, typically by dendritic cells (DCs), but whether priming occurs in the lungs in COPD is unknown. METHODS: We used lung tissue and in some cases peripheral blood from patients undergoing clinically indicated resections to determine in vitro killing of CD326+ lung epithelial cells by isolated lung CD56+ NKs. We also measured the cytotoxicity of unprimed blood NKs after preincubation with lung DCs. To investigate mechanisms of DC-mediated priming, we used murine models of COPD induced by cigarette smoke (CS) exposure or by polymeric immunoglobulin receptor (pIgR) deficiency, and blocked IL-15Rα (IL-15 receptor α subunit) trans-presentation by genetic and antibody approaches. RESULTS:Human lung NKs killed isolated autologous lung epithelial cells; cytotoxicity was increased (P = 0.0001) in COPD, relative to smokers without obstruction. Similarly, increased lung NK cytotoxicity compared with control subjects was observed in CS-exposed mice and pIgR-/- mice. Blood NKs both from smokers without obstruction and subjects with COPD showed minimal epithelial cell killing, but in COPD, preincubation with lung DCs increased cytotoxicity. NKs were primed by CS-exposed murine DCs in vitro and in vivo. Inhibiting IL-15Rα trans-presentation eliminated NK priming both by murineCS-exposed DCs and by lung DCs from subjects with COPD. CONCLUSIONS: Heightened NK cytotoxicity against lung epithelial cells in COPD results primarily from lung DC-mediated priming via IL-15 trans-presentation on IL-15Rα. Future studies are required to test whether increased NK cytotoxicity contributes to COPD pathogenesis.
Authors: Vasiliy V Polosukhin; Justin M Cates; William E Lawson; Rinat Zaynagetdinov; Aaron P Milstone; Pierre P Massion; Sebahat Ocak; Lorraine B Ware; Jae Woo Lee; Russell P Bowler; Alexey V Kononov; Scott H Randell; Timothy S Blackwell Journal: Am J Respir Crit Care Med Date: 2011-04-21 Impact factor: 21.405
Authors: Assaf Marcus; Benjamin G Gowen; Thornton W Thompson; Alexandre Iannello; Michele Ardolino; Weiwen Deng; Lin Wang; Nataliya Shifrin; David H Raulet Journal: Adv Immunol Date: 2014 Impact factor: 3.543
Authors: Ingel K Demedts; Ken R Bracke; Geert Van Pottelberge; Dries Testelmans; Geert M Verleden; Frank E Vermassen; Guy F Joos; Guy G Brusselle Journal: Am J Respir Crit Care Med Date: 2007-03-01 Impact factor: 21.405
Authors: Bradley W Richmond; Robert M Brucker; Wei Han; Rui-Hong Du; Yongqin Zhang; Dong-Sheng Cheng; Linda Gleaves; Rasul Abdolrasulnia; Dina Polosukhina; Peter E Clark; Seth R Bordenstein; Timothy S Blackwell; Vasiliy V Polosukhin Journal: Nat Commun Date: 2016-04-05 Impact factor: 14.919
Authors: Wassim W Labaki; Lucas M Kimmig; Gökhan M Mutlu; MeiLan K Han; Surya P Bhatt Journal: Am J Respir Crit Care Med Date: 2019-06-15 Impact factor: 21.405
Authors: Jonas Eriksson Ström; Jamshid Pourazar; Robert Linder; Anders Blomberg; Anne Lindberg; Anders Bucht; Annelie F Behndig Journal: Respir Res Date: 2018-12-07
Authors: Robert M Tighe; Elizabeth F Redente; Yen-Rei Yu; Susanne Herold; Anne I Sperling; Jeffrey L Curtis; Ryan Duggan; Suchitra Swaminathan; Hideki Nakano; William J Zacharias; William J Janssen; Christine M Freeman; Ryan R Brinkman; Benjamin D Singer; Claudia V Jakubzick; Alexander V Misharin Journal: Am J Respir Cell Mol Biol Date: 2019-08 Impact factor: 6.914
Authors: Grace E Cooper; Kristoffer Ostridge; Salim I Khakoo; Tom M A Wilkinson; Karl J Staples Journal: Front Immunol Date: 2018-07-20 Impact factor: 7.561